​

Caris Life Sciences Ownership | Who Owns Caris Life Sciences?

OverviewChart

Caris Life Sciences Ownership Summary

Caris Life Sciences is owned by 616.65% institutional investors, 48.16% insiders. Sixth street partners management company is the largest institutional shareholder, holding 140.66% of CAI shares.

CAI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCaris Life Sciences616.65%48.16%-564.80%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sixth street partners management company24.39M140.66%$651.58M
Coatue management10.14M58.50%$271.00M
Braidwell lp7.32M42.20%$195.49M
T. rowe price investment management7.30M42.13%$195.16M
Price t rowe associates inc /md/6.76M39.00%$180.65M
Silver lake group5.29M30.52%$141.38M
Orbimed advisors3.03M17.51%$81.09M
Pointstate capital lp2.50M14.41%$66.76M
Canada pension plan investment board1.32M7.63%$35.34M
Clearbridge investments1.26M7.25%$33.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sixth street partners management company24.39M51.71%$651.58M
Pura vida investments45.00K14.45%$2.40M
Braidwell lp7.32M6.69%$195.49M
Harbert fund advisors80.00K6.41%$2.14M
Silver lake group5.29M2.81%$141.38M
Orbimed advisors3.03M2.03%$81.09M
First light asset management443.04K1.46%$11.25M
Rock springs capital management lp793.65K1.32%$21.21M
Perceptive advisors1.10M1.09%$29.34M
Pointstate capital lp2.50M1.02%$66.76M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company24.39M51.71%24.39M
Coatue management10.14M0.75%10.14M
Braidwell lp7.32M6.69%7.32M
T. rowe price investment management7.30M0.12%7.30M
Price t rowe associates inc /md/6.76M0.02%6.76M

Top Sellers

HolderShares% AssetsChange
Cedar mountain advisors5.00-5.00
Srs capital advisors19.00-19.00
Financial management professionals20.000.00%20.00
Newedge advisors200.00-200.00
Nomura asset management562.00-562.00

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company24.39M51.71%24.39M$651.58M
Coatue management10.14M0.75%10.14M$271.00M
Braidwell lp7.32M6.69%7.32M$195.49M
T. rowe price investment management7.30M0.12%7.30M$195.16M
Price t rowe associates inc /md/6.76M0.02%6.76M$180.65M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025117-106,907,974-616-117---
Dec 31, 20211-99.25%1,399-99.99%-0.00%--100.00%--100.00%
Sep 30, 2021133-13.07%15,280,7190.15%881.13%63-16.00%46-14.81%
Jun 30, 20211534.08%15,257,6658.40%881.33%75-12.79%5428.57%
Mar 31, 202114723.53%14,075,013-5.87%811.14%8617.81%4250.00%

Recent Insider Transactions

DateNameRoleActivityValue
Mar 29, 2019Sawka Gary-Sell$232.30K
Feb 26, 2019Garcia Victor President and CEOBuy$233.70K
Feb 27, 2019Garcia Victor President and CEOBuy$2.27K
Jun 01, 2018Garcia Victor President and CEOBuy$218.25K
Jun 01, 2018Garcia Victor President and CEOBuy$24.23K

CAI Ownership FAQ

Who Owns Caris Life Sciences?

Caris Life Sciences shareholders are primarily institutional investors at 616.65%, followed by 48.16% insiders and -564.81% retail investors. The average institutional ownership in Caris Life Sciences's industry, Biotech Stocks , is 306.59%, which Caris Life Sciences exceeds.

Who owns the most shares of Caris Life Sciences?

Caris Life Sciences’s largest shareholders are Sixth street partners management company (24.39M shares, 140.66%), Coatue management (10.14M shares, 58.50%), and Braidwell lp (7.32M shares, 42.20%). Together, they hold 241.36% of Caris Life Sciences’s total shares outstanding.

Does Blackrock own Caris Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Caris Life Sciences.

Who is Caris Life Sciences’s biggest shareholder by percentage of total assets invested?

Sixth street partners management company is Caris Life Sciences’s biggest shareholder by percentage of total assets invested, with 51.71% of its assets in 24.39M Caris Life Sciences shares, valued at 651.58M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools